Studies on antibacterial activity and diversity of cultivable actinobacteria isolated from mangrove soil in futian and maoweihai of China
Mangrove is a rich and underexploited ecosystem with great microbial diversity for discovery of novel and chemically diverse antimicrobial compounds. The goal of the study was to explore the pharmaceutical actinobacterial resources from mangrove soil and gain insight into the diversity and novelty of cultivable actinobacteria. Consequently, 10 mangrove soil samples were collected from Futian and Maoweihai of China, and the culture-dependent method was employed to obtain actinobacteria. A total of 539 cultivable actinobacteria were isolated and distributed in 39 genera affiliated to 18 families of 8 orders by comparison analysis of partial 16S rRNA gene sequences. The dominant genus was Streptomyces (16.0 %), followed by Microbacterium (14.5 %), Agromyces (14.3 %), and Rhodococcus (11.9 %). Other 35 rare actinobacterial genera accounted for minor proportions. Notably, 11 strains showed relatively low 16S rRNA gene sequence similarities (< 98.65 %) with validly described species. Based on genotypic analyses and phenotypic characteristics, 115 out of the 539 actinobacterial strains were chosen as representative strains to test their antibacterial activities against “ESKAPE” bacteria by agar well diffusion method and antibacterial mechanism by the double fluorescent protein reporter system. Fifty-four strains in 23 genera, including 2 potential new species, displayed antagonistic activity in antibacterial assay. Meanwhile, 5 strains in 3 genera exhibited inhibitory activity on protein biosynthesis due to ribosome stalling. These results demonstrate that cultivable actinobacteria from mangrove soil are potentially rich sources for discovery of new antibacterial metabolites and new actinobacterial taxa.
Citations by journals
1
2
3
|
|
Frontiers in Microbiology
|
Frontiers in Microbiology
3 publications, 21.43%
|
Antibiotics
|
Antibiotics
1 publication, 7.14%
|
3 Biotech
|
3 Biotech
1 publication, 7.14%
|
Marine Drugs
|
Marine Drugs
1 publication, 7.14%
|
Frontiers in Bioengineering and Biotechnology
|
Frontiers in Bioengineering and Biotechnology
1 publication, 7.14%
|
BMC Microbiology
|
BMC Microbiology
1 publication, 7.14%
|
Current Microbiology
|
Current Microbiology
1 publication, 7.14%
|
mSphere
|
mSphere
1 publication, 7.14%
|
Polish Journal of Microbiology
|
Polish Journal of Microbiology, 1, 7.14%
Polish Journal of Microbiology
1 publication, 7.14%
|
Journal of Pure and Applied Microbiology
|
Journal of Pure and Applied Microbiology, 1, 7.14%
Journal of Pure and Applied Microbiology
1 publication, 7.14%
|
1
2
3
|
Citations by publishers
1
2
3
4
|
|
Frontiers Media S.A.
|
Frontiers Media S.A.
4 publications, 28.57%
|
Springer Nature
|
Springer Nature
3 publications, 21.43%
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
2 publications, 14.29%
|
American Society for Microbiology
|
American Society for Microbiology
1 publication, 7.14%
|
Polskie Towarzystwo Mikrobiologow/Polish Society of Microbiologists
|
Polskie Towarzystwo Mikrobiologow/Polish Society of Microbiologists, 1, 7.14%
Polskie Towarzystwo Mikrobiologow/Polish Society of Microbiologists
1 publication, 7.14%
|
Journal of Pure and Applied Microbiology
|
Journal of Pure and Applied Microbiology, 1, 7.14%
Journal of Pure and Applied Microbiology
1 publication, 7.14%
|
1
2
3
4
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.